Contents

Current Pharmaceutical Design, Volume 15 - Number 27

Editorial [Hot Topic: Drugs Targeting Atherosclerosis: Current and Emerging Approaches (Executive Editors: Vangelis G. Manolopoulos and Anna Tavridou)]

, 15(27): 3091 - 3093

Vangelis G. Manolopoulos and Anna Tavridou


DOI: 10.2174/138161209789058039




Anti-Atherosclerotic Molecules Targeting Oxidative Stress and Inflammation

, 15(27): 3094 - 3107

A. Adameova, Y. J. Xu, T. A. Duhamel, P. S. Tappia, L. Shan and N. S. Dhalla


DOI: 10.2174/138161209789058048




Rho Kinase: An Important Mediator of Atherosclerosis and Vascular Disease

, 15(27): 3108 - 3115

Qian Zhou and James K. Liao


DOI: 10.2174/138161209789057986




Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis

, 15(27): 3116 - 3132

Magnus Back


DOI: 10.2174/138161209789058020




Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System

, 15(27): 3133 - 3145

Huige Li and Ulrich Forstermann


DOI: 10.2174/138161209789058002




Recent Advances on the Antiatherogenic Effects of HDL-Derived Proteins and Mimetic Peptides

, 15(27): 3146 - 3166

Maria P. Petraki, Polyxeni T. Mantani and Alexandros D. Tselepis


DOI: 10.2174/138161209789057977




EP2300 Compounds: Focusing on the Antiatherosclerotic Properties of Squalene Synthase Inhibitors

, 15(27): 3167 - 3178

A. Tavridou and V. G. Manolopoulos


DOI: 10.2174/138161209789057968




Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?

, 15(27): 3179 - 3192

N. Papanas and E. Maltezos


DOI: 10.2174/138161209789057995




Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases

, 15(27): 3193 - 3206

M. Zaiou, H. Benachour, J. B. Marteau, S. Visvikis-Siest and G. Siest


DOI: 10.2174/138161209789058011




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science